AAPS 2024 PharmSci 360

Salt Palace Convention Center 90 South West Temple,, Salt Lake City, UT, United States

Join us at AAPS 2024. Booth #1610 PharmSci 2024 brings together leading researchers from academia and industry. You will hear about […]

AusBiotech 2024

Melbourne Convention and Exhibition Centre 1 Convention Centre Pl, South Wharf, Melbourne, VIC, Australia

Join us at AusBiotech 2024. Booth #76   For over 38 years, the AusBiotech conference has served as the leading […]

ACT 2024 Annual Meeting

JW Marriott, Austin, Texas 110 E 2nd St, Austin, TX, United States

American College of Toxicology. 45th Annual Meeting (2024) 📍 Booth  208   The Annual Meeting is the heart of ACT. […]

EIP

EIP Altis Grand Hotel, Rua Barata Salgueiro 50, Lisbon, Lisboa, Portugal

European Immunogenicity Platform 16th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals Join us at EIP 2025  

SOT

Orange County Convention Center Orange County Convention Center West Concourse, 9800 International Drive, Orlando, FL, United States

SOT 64th Annual Meeting and ToxExpo Join us at SOT 2025 Booth # 706

WRIB

Hilton New Orleans Riverside Hilton New Orleans Riverside​ 2 Poydras St., New Orleans, LA, United States

19th WRIB Workshops on Recent Issues in Bioanalysis Join us at WRIB 2025

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.